MiLaboratories
Sunnyvale
About MiLaboratories
MiXCR is an ultimate software platform for analysis of Next-Generation Sequencing (NGS) data for immune profiling. It’s widely used to empower R&D in vaccine development, CAR-T therapies, antibody discovery and other areas. 8 out of 10 Big Pharma companies choose MiXCR for studying immune system. Aiming to support non-profit research, we provide MiXCR for free for academic and non-commercial use. For years, MiXCR is being the number one solution for immune system studies in academia and industry.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $12.4M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2024)
- Website: milaboratories.com
- Phone: 408-219-8157
Industries & Categories
Biotechnology, Genetics, Software
Social Profiles
Canonical: https://fsome.com/organization/milaboratories-114967 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.